Recap: Denali Therapeutics Q2 Earnings

Denali Therapeutics DNLI reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Denali Therapeutics beat estimated earnings by 12.73%, reporting an EPS of $-0.48 versus an estimate of $-0.55.

Revenue was up $29.54 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 3.84% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Denali Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.